OTC Markets OTCPK - Delayed Quote USD

UMAX Group Corp. (UMAX)

0.0001
0.0000
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Loading Chart for UMAX
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0001 x --
  • Ask 0.0002 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0011
  • Volume 7,500
  • Avg. Volume 5,588
  • Market Cap (intraday) 7,047
  • Beta (5Y Monthly) 16.61
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company's products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.

www.umaxcorp.com

--

Full Time Employees

April 30

Fiscal Year Ends

Recent News: UMAX

View More

Performance Overview: UMAX

Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

UMAX
0.00%
S&P 500 (^GSPC)
1.62%

1-Year Return

UMAX
50.00%
S&P 500 (^GSPC)
10.00%

3-Year Return

UMAX
98.00%
S&P 500 (^GSPC)
59.40%

5-Year Return

UMAX
99.17%
S&P 500 (^GSPC)
96.53%

Compare To: UMAX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UMAX

View More

Valuation Measures

Annual
As of 6/13/2025
  • Market Cap

    7.05k

  • Enterprise Value

    2.62M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -97.55%

  • Return on Equity (ttm)

    -233.54%

  • Revenue (ttm)

    13.5k

  • Net Income Avi to Common (ttm)

    -120.4k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    147.34k

  • Total Debt/Equity (mrq)

    43.23%

  • Levered Free Cash Flow (ttm)

    -69.56k

Research Analysis: UMAX

View More

Company Insights: UMAX

Research Reports: UMAX

View More

People Also Watch